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Trypanosoma brucei gambiense causes human African trypanosomiasis (HAT).
Between 1990 and 2015, almost 440 000 cases were reported. Large-scale screening of populations at risk, drug donations, and efforts by national and international stakeholders have brought the epidemic under control with <2200 cases in 2016. The World Health Organization (WHO) has set the goals of gambiense-HAT elimination as a public health problem for 2020, and of interruption of transmission to humans for 2030. Latent human infections and possible animal reservoirs may challenge these goals. It remains largely unknown whether, and to what extend, they have an impact on gambiense-HAT transmission. We argue that a better understanding of the contribution of human and putative animal reservoirs to gambiense-HAT epidemiology is mandatory to inform elimination strategies.
Can Cryptic Reservoirs in Humans and Animals Compromise the Sustainable Elimination of gambiense-HAT?
HAT is caused by two closely related parasites that are transmitted by tsetse flies. Trypanosoma brucei gambiense is responsible for the Western and Central African form of the disease and Trypanosoma brucei rhodesiense occurs in Eastern and Southern Africa -both forms of the disease are usually fatal if untreated [1] . Between 1990 and 2016, a total of 437 971 cases of gambiense-HAT were reported, with a peak of 37 385 cases in 1998
i . Thanks to large-scale deployment of a serological screening test (CATT/T. b. gambiense) (see Glossary), drug donations, and intense efforts by national and international stakeholders, this epidemic has been brought under control, with fewer than 2200 cases reported in 2016. This represents a marked reduction in human suffering caused by the disease. Inspired by this progress, the WHO has set elimination of gambiense-HAT as a target for the near future: elimination as a public health problem by 2020 and the interruption of transmission to humans by 2030 ii .
The rationale to shift from HAT control to elimination is based on several arguments, such as the epidemiological vulnerability of gambiense-HAT as a presumed anthroponotic infection, Innovative tools may contribute to the achievement of elimination; these tools include rapid diagnostic tests, improved tsetse-control tools, and an oral drug to treat both stages of disease.
Research is revealing associations between infection outcome, including self-cure, and mutations within genes involved in immune responses.
Patient-derived T. b. gambiense strains can cycle in animals and tsetse flies without losing infectivity to humans. Molecular and serological techniques facilitate new studies on naturally infected animals as putative reservoir hosts.
Mathematical modelling supports the hypothesis that human or animal reservoirs drive transmission, and they, or the tsetse vectors, could be targeted to swiftly impact transmission. Ongoing modelling will assess possible recrudescence via reservoirs. years was documented [11] . Whether latently infected persons transmit the parasite sexually [12] , and whether sexual and congenital transmission plays a significant role in the epidemiology of gambiense-HAT [13] , remains hypothetical. In Guinea, asymptomatic or latent infections were found to have consistently high titres in CATT/T. b. gambiense and to be positive in the immune trypanolysis test, although no parasites could be detected in blood or lymph node fluid during a 2-year follow-up period [14] . This observation is in line with the fact that trypanosomes can survive in the extravascular spaces of diverse organs such as the heart, the central nervous system, and the skin [15] [16] [17] . Experimental infections in animals confirmed that parasites may be undetectable in the blood but hidden in different organs and tissues [18] [19] [20] [21] Other studies have found associations between the innate and the adaptive immune response and infection outcome, for example, self-cure and high levels of interleukin-8 (IL-8); latent infection and high levels of IL-6 or specific interferon-g-producing T cells; disease progression and high levels of IL-10, TNF-a, and sHLA-G [31-33]. In view of the global elimination of HAT, it is of the utmost importance to clarify the extent to which these human reservoirs contribute to the transmission of the parasite and hence to gambiense-HAT persistence and potential resurgence.
Animal Reservoir
Compared to latent infections in humans, our current knowledge of T. b. gambiense infections in animals is very limited and fragmented. The presence of T. b. gambiense in animals has been demonstrated in several studies ( Figure 1 ) [34, 35] . Several authors have suggested that animals can act as a reservoir for gambiense-HAT [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . In rhodesiense-HAT, sustained parasite transmission cycles exist in both livestock and wildlife, from which the parasite can spill over to humans [46] . For T. b. gambiense, despite early data generated on its infectivity and transmissibility in animals, the epidemiological significance of any animal reservoir is not well understood and may depend on the specific ecosystem of the HAT focus. Even if the parasite can be transmitted to and from animals, factors such as the proportion of blood-feeding on that species by tsetse will determine the epidemiological significance of the species to act as a maintenance population or part of a maintenance community. T. b. gambiense can infect a variety of domestic animals and wildlife, as shown in Table 1 . Following infection, most of these animals remain asymptomatic and generally show low to very low parasitaemia. For instance, in pigs infected with a T. b. gambiense strain isolated from a human patient, only xenodiagnosis and blood culture succeeded in revealing an infection but conventional microscopy failed to detect parasites [47] [48] [49] [50] [51] . Moreover, experimental studies have shown that human-derived T. b. gambiense strains that were cyclically transmitted by tsetse flies between animals for more than a year remained transmissible to humans [48] .
Studying natural T. b. gambiense infections in animals is challenging. Major drawbacks are the usually low parasitaemia and the necessity to distinguish T. b. gambiense from other trypanosome species such as T. brucei brucei, T. congolense, T. vivax, T. suis, and T. simiae. In particular, T. b. gambiense is morphologically identical to the nonhuman infective T. b. brucei.
Among the molecular tests, only those targeting the single-copy TgsGP gene are gambiensespecific, thus limiting their analytical sensitivity to >100 trypanosomes per ml of blood [52, 53] . Biochemical assays, such as isoenzyme profiling, are only applicable on parasite strains that have been isolated and adapted to laboratory rodents or to in vitro cultures [54] [55] [56] , and phenotypic assays such as the blood incubation infectivity test are only readily applicable on isolated strains and are not fully gambiense-specific [57] . Tests that detect antibodies against gambiense-specific antigens, such as the variant surface glycoproteins (VSGs) LiTat 1.3 and LiTat 1.5, may be more useful in revealing T. b. gambiense infections in animals. However, the immune trypanolysis test (TL), which is considered 100% specific in humans, still has to be validated in different species of animals. Ancillary information on the T. b. gambiense animal reservoir can be drawn from analysing T. b. gambiense infection in tsetse, in combination with its feeding behaviour, to assess the vectorial transmission of the parasite from the animal reservoir to humans [58] . In summary, there is a need to further improve our tools and increase our understanding regarding the importance of an animal reservoir in gambiense-HAT [9] . They remain asymptomatic without detectable parasites (PÀ) for several years, although they are consistently positive in the immune trypanolysis test (TL+). Moreover, some of them may become immune trypanolysis-negative (TLÀ) over time, suggesting that they self-cured and therefore cannot transmit the parasite any more. (uninfected), without specific antibodies (TLÀ) and without parasites (PÀ) become infected with T. b. gambiense, they undergo an early phase of the disease with detectable parasitaemia (P+) but without detectable specific antibodies. Thereafter, most of them develop the disease (HAT patient) and are characterised by specific antibodies (TL+) and detectable parasitaemia (P+). Some remain asymptomatic (latent infection) with detectable specific antibodies but without detectable parasites (TL+, PÀ). Evidence for self-cure comes from asymptomatic people who also eventually become negative for specific antibodies (TLÀ, PÀ).
Glossary
geographical name is given (locality, region, and river). 
Filling the Knowledge Gaps
The presence of multiple reservoirs is a critical obstacle to the sustained elimination of any infectious agent [60] . For example, when the Guinea worm eradication programme was rolled out, the possibility of an animal reservoir was initially overlooked, but the recent finding of Guinea worm infections in dogs led to the hypothesis that dogs could have acted as a reservoir that caused the reappearance of human cases in Chad [61] . The existence of a human reservoir, in the form of post-kala-azar dermal leishmaniasis, and possibly also latent infections, is a challenge for the sustained elimination of visceral leishmaniasis (VL) from the Indian subcontinent [62] .
The importance of investigating how HAT can re-emerge in so-called silent foci is clearly illustrated by the fact that a 9-year-old child was diagnosed with gambiense-HAT in Ghana in 2013, 10 years after the last detected case [63] . Also, the finding of a gambiense-specific PCRpositive squirrel in Equatorial Guinea on Luba island in 2014, where the last human HAT case was reported in 1995, is worrying [43] . Therefore, in the context of gambiense-HAT elimination, a key question is whether human and/or animal reservoirs are capable of maintaining Tables S1 and S2 in [80] susceptible vectors after they were fed on an individual suspected of being infected with the parasite; in HAT, the vectors used are teneral tsetse flies.
transmission and causing a resurgence of the disease in different geographical areas and epidemiological settings (see Outstanding Questions).
As with the mathematical modelling of other neglected tropical diseases [64] , models on HAT epidemiology may help to improve our epidemiological knowledge and inform elimination strategies. Models can explore if, and how, animal and human reservoirs could sustain endemicity in HAT foci [65] . However, model predictions heavily depend on the availability of accurate information for their construction, parameterisation, and fitting. To date, a few models have attempted to infer the contribution of reservoirs in gambiense-HAT transmission maintenance by fitting to human epidemiological data. Funk et al. [66] suggested that animals were necessary for persistent transmission in Bipindi focus in Cameroon. Studies of existing gambiense-HAT models in a few foci (i.e., D. R. Congo, Guinea, and Chad) suggest that some type of additional infection reservoir is needed to match the observed dynamics of reported HAT cases [5, 67, 68] . This could arise from another human reservoir (including undiagnosed and latent infections), an animal reservoir, and/or heterogeneities in human risk exposure and surveillance coverage. A different modelling exercise considered the implications on transmission and control of whether animals function as reservoirs or as zooprophylaxis but did not address which was more likely [69] .
Due to the current lack of knowledge surrounding latently infected people (including their frequency, disease progression, their relative infectivity to tsetse, and the duration of this infectious stage) modelling latent infections in humans is challenging, and these uncertainties will impact the models' predictions. In particular, latent infections have only been explicitly incorporated in one gambiense-HAT model, and the potential role of these individuals in maintaining transmission or hindering elimination has yet to be fully analysed [70] . Arguably, long-duration infections, which eventually progress to late-stage disease, are captured by the stage 1 exponential distributions used in many modelling frameworks, but modifications could better represent self-cure and nondetection of latent infections in active screening. Many recent modelling studies have concluded that existing vector-control methods have the ability to quickly reduce transmission to and from tsetse to all hosts, and may be critical for elimination in regions where reservoirs exist [67] [68] [69] [70] [71] [72] .
New data and investigations into latent human infections and animal infections will help shape the way in which future models are developed and parameterised by factoring in improved biological evidence. Some critical gaps in our knowledge, which influence modelling choices, are shown in Figure 2 (Key Figure) . As well as refining formulation and parameterisation of the existing deterministic models, it is also clear that a new generation of models is needed. H umans Figure 2 . Solid lines represent progression between disease states, and dashed lines represent transmission of the parasites to and from the tsetse vector. Red boxes denote people or animals that may be infective to tsetse, with the darker shades denoting possible greater infectiveness. The figure highlights key unknown elements in disease progression and transmission including: (1) the probability of an infection leading to latent or stage 1 disease in humans -if, and how frequently; (2) self-cure of infected humans or (3) animals arises; (4) the duration of latent infection in humans, or (5) any infections in animals; and (6) the relative probability of transmission to tsetse from different types of infections (accounting for host feeding preferences).
Stochastic models are better suited to capture the chance events that determine the role of cryptic reservoirs and their implications for elimination. In conclusion, improved mathematical models on HAT epidemiology, combined with additional field and experimental data, are needed to help understand the respective roles of these reservoirs.
Concluding Remarks
We believe that attaining the elimination (zero transmission) target of gambiense-HAT by 2030 is feasible but, as observed for other neglected tropical diseases, latent infections -whether human or animal -may constitute cryptic parasite reservoirs and thus add another challenge to sustained elimination. To inform evidence-based elimination strategies, a better understanding of the contribution of these putative human and animal reservoirs on the epidemiology of gambiense-HAT is required, more in particular on (i) the frequency and duration of latent human infections and infections in animals, (ii) the infectiveness of latent human infections and animal reservoirs to tsetse flies, (iii) the ability of latent human infections or animal reservoirs to sustain transmission in interepidemic periods, and (iv) the possible existence of an animal transmission cycle in the absence of human transmission and its ability to seed a new transmission cycle in humans. To investigate these issues, we urgently need to improve our toolbox for the identification of latent and self-cured infections, including prognostic and diagnostic markers. Also, more accurate and preferably high-throughput tests to detect and monitor T. b. gambiense infections in animals should be developed, along with improved mathematical models for exploration of epidemiological hypotheses. 
